EirGenix, Inc. Enters Into Global License Agreement for the Commercialization of its Biosimilar Drug

NEW TAIPEI CITY, Taiwan, April 30, 2019 /PRNewswire/ -- EirGenix, Inc. announced today that it has entered into a license agreement with global generic and ... Lees verder

Bron:

ANP Pers support